Cargando…

The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer

BACKGROUND: The treatment of differentiated thyroid cancer (DTC) ends in full recovery in 80% of cases. However, in 20% of cases local recurrences or distant metastases are observed, for this reason DTC patients are under life-long follow-up. The most sensitive marker for recurrence is stimulated th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalska, Aldona, Pałyga, Iwona, Gąsior-Perczak, Danuta, Walczyk, Agnieszka, Trybek, Tomasz, Słuszniak, Anna, Mężyk, Ryszard, Góźdź, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521804/ https://www.ncbi.nlm.nih.gov/pubmed/26230494 http://dx.doi.org/10.1371/journal.pone.0133852

Ejemplares similares

Diagnostic performance evaluation of post-operative serum calcitonin (CT) levels as a factor for good prognosis in medullary thyroid carcinoma (MTC)
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2013)

Variation of the epidemiological structure of thyroid cancer between year 2000 and 2012
por: Kowalska, Aldona, et al.
Publicado: (2013)

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2017)

Coexisting Germline CHEK2 and Somatic BRAF(V600E) Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2019)

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence
por: Kowalska, Aldona, et al.
Publicado: (2016)

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population
por: Kowalik, Artur, et al.
Publicado: (2017)

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2018)

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma
por: Szymonek, Monika, et al.
Publicado: (2017)

Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients
por: Walczyk, Agnieszka, et al.
Publicado: (2020)

Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2021)

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023)

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
por: Hińcza, Kinga, et al.
Publicado: (2020)

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2021)

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications
por: Kowalik, Artur, et al.
Publicado: (2017)

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
por: Gajowiec, Aleksandra, et al.
Publicado: (2021)

Telomeres and telomerase in oncogenesis
por: Trybek, Tomasz, et al.
Publicado: (2020)

Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease
por: Lewandowski, Krzysztof C, et al.
Publicado: (2012)

Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A Case Report
por: Gonet, Agnieszka, et al.
Publicado: (2020)

Evaluation of ultrasound-guided fine needle aspiration biopsy (USG-FNAB) of thyroid nodules: 12 years of accepted diagnostic algorithm in Holycross Cancer Centre (HCC) in Kielce
por: Sygut, Jacek, et al.
Publicado: (2013)

Effectiveness analysis of papillary thyroid carcinoma (PTC) diagnostics in Holycross Cancer Centre (HCC) in Kielce according to fine needle aspiration biopsy quality assurance program in pathology department between years 2001 and 2012
por: Sygut, Jacek, et al.
Publicado: (2013)

Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
por: Jeong, Eugene, et al.
Publicado: (2019)

Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancy
por: Andersen, Stine Linding, et al.
Publicado: (2022)

TSH cut off point based on depression in hypothyroid patients
por: Talaei, A, et al.
Publicado: (2017)

Primary Cilia Mediate TSH-Regulated Thyroglobulin Endocytic Pathways
por: Lee, Junguee, et al.
Publicado: (2021)

Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis
por: Barwinek, Katarzyna, et al.
Publicado: (2020)

Changes in TSH, T4, T3 and Thyroglobulin Levels throughout Total Thyroidectomy
por: Senese, Nora, et al.
Publicado: (2022)

Comparing the effectiveness of stimulation using rhTSH and thyroid hormone withdrawal in the treatment of thyroid cancer
por: Kowalska, Aldona
Publicado: (2015)

The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature
por: Karvounis, Evangelos, et al.
Publicado: (2021)

Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results
por: Sandúa, Amaia, et al.
Publicado: (2020)

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity
por: Zajkowska, Klaudia, et al.
Publicado: (2020)

Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
por: Ha, Jeonghoon, et al.
Publicado: (2017)

Optimal cut-off values for anthropometric measures of obesity in screening for cardiometabolic disorders in adults
por: Macek, Pawel, et al.
Publicado: (2020)

Are molecular tests necessary to diagnose NIFTP?
por: Kuchareczko, Artur, et al.
Publicado: (2021)

Cut-off Value for Thyroglobulin Washout Concentration in the Detection of Cervical Lymph Node Metastases in Patients after Thyroidectomy Due to Differentiated Thyroid Cancer
por: Mikosiński, Paweł, et al.
Publicado: (2023)

Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
por: Przybycień, Piotr, et al.
Publicado: (2022)

Canonical TSH Regulation of Cathepsin-Mediated Thyroglobulin Processing in the Thyroid Gland of Male Mice Requires Taar1 Expression
por: Qatato, Maria, et al.
Publicado: (2018)

Impact of Thyroid Tissue Status on the Cut-Off Value of Lymph Node Fine-Needle Aspiration Thyroglobulin Measurements in Papillary Thyroid Cancer
por: Zhai, L., et al.
Publicado: (2022)

Optimal Body Fat Percentage Cut-Off Values in Predicting the Obesity-Related Cardiovascular Risk Factors: A Cross-Sectional Cohort Study
por: Macek, Pawel, et al.
Publicado: (2020)

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer
por: Ledwon, Aleksandra, et al.
Publicado: (2021)

Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation
por: Walczyk, Agnieszka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ck4ak5od05rmmvkq7lnt1q9c8o